Quotes 5-day view End-of-day quote Tokyo Stock Exchange
09/14/2020
09/15/2020
09/16/2020
09/17/2020
09/18/2020
Date
1632
1616
1611
1619
1626.5
Last
3507900
3680100
3592000
2942100
5881900
Volume
+0.71% -0.98% -0.31% +0.50% +0.46% Change
Sales 2021
1 274 B 12 183 M 12 183 M
Net income 2021
205 B 1 956 M 1 956 M
Net cash position 2021
450 B 4 301 M 4 301 M
P/E ratio 2021
14,7x
Yield 2021
2,59%
Sales 2022
1 347 B 12 876 M 12 876 M
Net income 2022
231 B 2 210 M 2 210 M
Net cash position 2022
578 B 5 524 M 5 524 M
P/E ratio 2022
12,9x
Yield 2022
2,85%
Capitalization
3 021 B 28 937 M 28 889 M
EV / Sales 2021
2,02x
EV / Sales 2022
1,81x
Nbr of Employees
15 883
Free-Float
99,2%
Astellas Pharma Inc. specializes in the research, development, manufacturing and marketing of pharmaceutical products. Products are especially for immune diseases, infectious diseases, skin diseases, cancer and urologic disorders.
Net sales are distributed geographically as follows: Japan (28.8%), Americas (34.5%) and others (36.7%).
Notations Surperformance© of Astellas Pharma Inc.
Trading Rating : Investor Rating :
All news about ASTELLAS PHARMA INC.
News in other languages on ASTELLAS PHARMA INC.
Chart ASTELLAS PHARMA INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ASTELLAS PHARMA INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Average target price
2 275,00 JPY
Last Close Price
1 626,50 JPY
Spread / Highest target
66,0%
Spread / Average Target
39,9%
Spread / Lowest Target
4,52%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
